Jennifer Burstein, Senior VP of Finance at Loxo Oncology, Inc. (LOXO), sold 4,000 shares at $166.14 ($667K) on 2018-09-12, disclosed to the SEC on 2018-09-14.
Open-market sale of $667k LOXO by Senior VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.14 | 550 | $91K | 13.7% |
| 2 | $166.14 | 550 | $91K | 13.7% |
| 3 | $167.25 | 200 | $33K | 5.0% |
| 4 | $168.78 | 200 | $34K | 5.1% |
| 5 | $168.79 | 200 | $34K | 5.1% |
| 6 | $170.95 | 300 |
| $51K |
| 7.7% |
| 7 | $165.53 | 750 | $124K | 18.6% |
| 8 | $165.53 | 750 | $124K | 18.6% |
| 9 | $166.76 | 500 | $83K | 12.5% |
| Total | $166.67 avg | 4,000 | $667K | 100% |
| Filing → |
| LOXO | SELL | 2018-10-05 | $742K | — | Filing → |
| LOXO | SELL | 2018-08-15 | $540K | — | Filing → |
| LOXO | SELL | 2018-07-11 | $281K | — | Filing → |